| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2004-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006521405-A |
| titleOfInvention |
Use of erythropoietin in seizure recovery |
| abstract |
The present invention demonstrates the effectiveness of EPO in promoting patient recovery following an ischemic event. The present invention shows that there is a longer previously understood window of opportunity for the initial use of EPO in the treatment of ischemic stroke. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169463-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5800505-B2 |
| priorityDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |